GENTFGENTFOTC
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank56
5Y CAGR+41.6%
Year-over-Year Change
Year-over-year research & development expense growth
5Y CAGR
+41.6%/yr
Long-term compound
Percentile
P56
Within normal range
vs 5Y Ago
5.7x
Strong expansion
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 4.33% |
| Q3 2025 | 3.92% |
| Q2 2025 | -12.58% |
| Q1 2025 | -2.56% |
| Q4 2024 | 3.79% |
| Q3 2024 | -7.71% |
| Q2 2024 | -5.24% |
| Q1 2024 | -4.96% |
| Q4 2023 | -11.17% |
| Q3 2023 | 12.11% |
| Q2 2023 | 0.13% |
| Q1 2023 | 3.85% |
| Q4 2022 | -43.85% |
| Q3 2022 | 129.55% |
| Q2 2022 | 6.74% |
| Q1 2022 | 21.35% |
| Q4 2021 | 2.48% |
| Q3 2021 | 8.95% |
| Q2 2021 | 6.04% |
| Q1 2021 | 8.75% |
| Q4 2020 | 0.76% |
| Q3 2020 | -22.61% |
| Q2 2020 | 2.71% |
| Q1 2020 | -7.36% |
| Q4 2019 | 13.38% |
| Q3 2019 | 7.92% |
| Q2 2019 | 8.08% |
| Q1 2019 | -0.24% |
| Q4 2018 | -1.72% |
| Q3 2018 | 17.63% |
| Q2 2018 | 45.13% |
| Q1 2018 | -0.97% |
| Q4 2017 | 13.83% |
| Q3 2017 | 7.01% |
| Q2 2017 | 10.93% |
| Q1 2017 | -0.56% |
| Q4 2016 | 11.73% |
| Q3 2016 | 34.85% |
| Q2 2016 | -7.22% |
| Q1 2016 | -10.97% |